XML 50 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
The components of the Company’s shared-based compensation expense for the years ended December 31, 2020, 2019 and 2018 are as follows:
Year Ended December 31,
202020192018
(in thousands)
Stock options$2,134 $2,623 $2,989 
Restricted stock and restricted stock units5,195 3,967 2,591 
Employee Stock Purchase Plan543 275 320 
Total pre-tax share-based compensation expense charged against income1
$7,872 $6,865 $5,900 
Total recognized tax (deficiency) benefit related to share-based compensation$(293)$196 $1,480 
1.Share-based compensation expense is recorded in cost of services and selling, general and administrative expense in the Company’s Consolidated Statements of Comprehensive Income.
Summary of Other Information of Stock Option Plans
A summary of stock options outstanding under the 2020 Plan and the 2012 Plan as of December 31, 2020 and changes during 2020 are as follows:
Stock Options Outstanding
Number of SharesWeighted Average Exercise Price
(in thousands)
December 31, 20192,107 $32.99 
Granted215 $24.49 
Exercised(164)$17.12 
Forfeited(12)$37.65 
Expired(48)$32.12 
December 31, 20202,098 $33.35 
Schedule of Assumption For Fair Value of Options Granted
The fair value of stock option awards granted in 2020, 2019 and 2018 were estimated on the dates of grant using the Black-Scholes option valuation model with the following assumptions:
Year Ended December 31,
202020192018
Risk-free interest rate1.8 %2.5 %2.1 %
Weighted average expected life6.6 years5.7 years5.8 years
Expected volatility26.5 %22.6 %21.5 %
Dividend yield3.2 %1.9 %1.5 %
Summarized Information of Stock Options Outstanding
The following table summarizes other information about the stock options at December 31, 2020:
December 31, 2020
(amounts in thousands, except per share data)
Outstanding:
Aggregate intrinsic value$2,720 
Weighted average remaining contractual life5.3 years
Exercisable:
Number of options1,375 
Weighted average exercise price$31.78 
Aggregate intrinsic value$1,944 
Weighted average remaining contractual life4.2 years
Summary of Outstanding Restricted Stock Units and Restricted Stock
A summary of the outstanding restricted stock units and restricted stock as of December 31, 2019 and changes during the year ended December 31, 2020 is as follows:
Restricted Stock Units and Restricted Stock
NumberWeighted Average Grant Date Fair Value
(in thousands)
December 31, 2019362 $43.24 
Granted309 $24.43 
Vested(94)$42.40 
Forfeited(16)$32.54 
December 31, 2020561 $33.31 
Weighted Average Grant-Date Fair Values and Intrinsic Values of Options Vested
The weighted average grant-date fair values and total fair values of restricted stock units and restricted stock vested during 2020, 2019 and 2018 were as follows:
Year Ended December 31,
202020192018
(in thousands, except per share data)
Weighted average grant-date fair value of restricted stock units granted$24.43 $40.49 $52.06 
Total fair value of restricted stock units and restricted shares vested$2,287 $2,399 $1,822 
Summary of ESPP Annual Offerings
The following table summarizes information about the Company's ESPP annual offerings for the years ended December 31, 2020, 2019 and 2018:
Year Ended December 31,
202020192018
(in thousands, except per share data)
Common shares purchased73 75 53 
Per common share purchase price$20.67 $20.67 $34.15 
Summary of Information Of SERP
The following table summarizes information about the SERP during the plan years ended December 31, 2020, 2019 and 2018:
Year Ended December 31,
 202020192018
(in thousands)
SERP expense 1
$512 $539 $547 
Treasury shares issued to fund SERP expense2
18 22 14 
Year end SERP trust account balance3
$54,729 $43,952 $39,766 
Unrealized gain (loss) recorded in SERP liability account$9,200 $7,353 $(1,469)
1.Both the SERP match and the deferrals are included in the selling, general and administrative caption in the Consolidated Statements of Comprehensive Income.
2.Shares related to the SERP match for each year are funded at the beginning of the subsequent year.
3.SERP trust account investments are recorded at their fair value which is based on quoted market prices. Differences between such amounts in the table above and the deferred compensation funding asset reported on the Consolidated Balance Sheets represent the value of Company Common Stock held in the Plan participants' trust accounts and reported by the Company as treasury stock in the Consolidated Balance Sheets.